Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
229.00    1.00 (0.44%)
Bid:
228.00
Ask:
229.00
Spread: 1.00 (0.439%)
Market Cap: £632.99m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Acquisition

6 Jan 2009 07:00

RNS Number : 1429L
Morgan Crucible Co PLC
06 January 2009
 



THE MORGAN CRUCIBLE COMPANY PLC ("MORGAN CRUCIBLE") INCREASES ITS STAKE IN NP AEROSPACE TO BECOME MAJORITY SHAREHOLDER

Morgan Crucible is pleased to announce it will be increasing its equity stake in NP Aerospace from 49% to 60% by acquiring 11% of the ordinary share capital of the company from the management and Employee Benefit Trust for a consideration of £12.2 million. As a result NP Aerospace will be fully consolidated in to the Morgan Crucible accounts with immediate effect.

NP Aerospace is a composite technical moulding and vehicle integration business that develops, manufactures and markets ballistic protective and other composite products in the defence and civil sectors. It is based in CoventryUK with approximately 300 employees and has a strong position in the UK with the Ministry of Defence. NP Aerospace has a high degree of experience and expertise in armour systems for military vehicle protection and has been responsible for integrating a significant number of vehicle systems, including Mastiff, used by the British Army. In addition, NP Aerospace enjoys unique areas of application know-how in products such as personal body armourmilitary helmets, explosive ordnance suits and protective kits for a wide range of vehicles.

The transaction for this 11% tranche of equity has been accelerated from the timetable in the original investment agreement of 1st August 2007 with the consideration payable ultimately dependent on the EBITDA achieved in 2009. Management and the Employee Benefit Trust retain a 40% equity stake and a phased process is in place for Morgan Crucible to acquire this remaining equity in four equal annual instalments starting in early 2010. The consideration payable for the future equity purchases will continue to be based on 7.25 times the EBITDA of the company for the relevant calendar year. 

Mark Robertshaw, Chief Executive Officer of Morgan Crucible said "I am delighted that we have accelerated the programme of purchasing the outstanding equity of NP Aerospace. Since our initial investment in August 2007 the relationship between Morgan Crucible and NP Aerospace has strengthened and both parties have capitalised on the many benefits that we bring to each other. NP Aerospace has enjoyed a year of significant growth in 2008 and is extremely well positioned to continue this track record in 2009, helped by Morgan Crucible's resources and global reach. Being able to consolidate the results of NP Aerospace in Morgan Crucible's accounts also means that the underlying performance and value of the NP Aerospace will now be fully visible in our financial reporting."

Roger Medwell, Chief Executive Officer of NP Aerospace said "Like Morgan Crucible, differentiation of our products by innovative use of our advanced materials continues to be our mission. Since the original investment in 2007, NP Aerospace and Morgan Crucible have worked effectively together, combining our complementary materials, ballistic protective and design expertise to develop a comprehensive range of solutions to defend against ever-changing threats. The NP Aerospace team look forward to working even more closely with Morgan Crucible to meet the demanding requirements of our customers and to capitalise on Morgan Crucible's infrastructure to realise the full potential of the business."

Notes for Class 2 purposes:

The total consideration paid by Morgan Crucible for this additional 11% of NP Aerospace is £12.2 million paid in cash. 10.1% has been acquired as of 5th January 2009 and it has been agreed that a further 0.9% will be acquired from the Employee Benefit Trust within the next two weeks.

In 2007 NP Aerospace revenues were £51.8 million and EBITDA £9.5 million, a margin of 18.4%. As at 31st December 2007 NP Aerospace had gross assets of £36.8 million.

(All the above numbers are quoted from the statutory accounts based on UK GAAP.)

The order book for the business currently stands at approximately £160 million.

For further enquiries:

Mark Robertshaw / Kevin Dangerfield  Morgan Crucible 01753 837300

Mike Smith / Robin Walker Finsbury 020 7251 3801

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXFSESENEFE
Date   Source Headline
5th Jun 20153:29 pmRNS2014 Environmental, Health and Safety Report
28th May 201511:22 amRNSHolding(s) in Company
20th May 20157:00 amRNSTrading Update
8th May 20153:51 pmRNSResult of AGM
16th Apr 20154:14 pmRNSDirector/PDMR Shareholding
2nd Apr 20158:40 amRNSDirector/PDMR Shareholding
31st Mar 20153:18 pmRNSHolding(s) in Company
31st Mar 20153:14 pmRNSDirector/PDMR Shareholding
31st Mar 201510:12 amRNSPublication of 2014 Annual Report
27th Mar 20159:41 amRNSDirector/PDMR Shareholding
26th Mar 20152:37 pmRNSDirector/PDMR Shareholding
25th Mar 20152:33 pmRNSDirector/PDMR Shareholding
24th Mar 20151:42 pmRNSDirector/PDMR Shareholding
24th Mar 20151:36 pmRNSDirector/PDMR Shareholding
2nd Mar 201512:32 pmRNSDirector/PDMR Shareholding
26th Feb 20152:05 pmRNSDirector/PDMR Shareholding
12th Feb 20157:00 amRNSFY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
30th Jan 20157:00 amRNSAppointment of Chief Executive Officer
23rd Dec 20142:03 pmRNSStatement under s.430 (2B) Companies Act 2006
23rd Dec 20142:00 pmRNSStatement under s. 430(2B) Companies Act 2006
18th Dec 201412:08 pmRNSHolding(s) in Company
18th Dec 201412:00 pmRNSDirector/PDMR Shareholding
16th Dec 201410:05 amRNSBlocklisting Interim Review
12th Dec 20141:05 pmRNSBoard Changes
3rd Dec 201410:47 amRNSDirector/PDMR Shareholding
1st Dec 20148:49 amRNSRejection of Vesuvius Proposal
1st Dec 20147:00 amRNSStatement of intention not to make an offer
11th Nov 20147:00 amRNSTrading Update
17th Oct 201410:17 amRNSMorgan Advanced Matereals - CDP Announcement
14th Oct 20149:29 amRNSHolding(s) in Company
2nd Oct 201411:25 amRNSDirector/PDMR Shareholding
29th Sep 20147:00 amRNSBoard Change
23rd Sep 20149:42 amRNSHolding(s) in Company
22nd Aug 201410:59 amRNSHolding(s) in Company
18th Aug 201410:16 amRNSHalf Yearly Report
5th Aug 20149:53 amRNSUNIVERSITY OF MANCHESTER PARTNERS WITH MORGAN
1st Aug 20149:18 amRNS£15m Composites & Defence Systems Contract Award
31st Jul 20142:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSHalf Year Results
18th Jul 20149:25 amRNSDirector Declaration
15th Jul 20147:00 amRNSAcquisition of Porextherm Dämmstoffe GmbH
14th Jul 20149:15 amRNSDirector Declaration
18th Jun 20148:16 amRNSChange of Directors' responsibilities
16th Jun 201412:01 pmRNSBlocklisting Interim Review
9th Jun 20143:10 pmRNSHolding(s) in Company
9th Jun 201412:28 pmRNSAcquisition of Porextherm Dämmstoffe GmbH
9th Jun 201410:39 amRNSDirector/PDMR Shareholding
9th May 20143:39 pmRNSResult of AGM
9th May 20147:00 amRNSInterim Management Statement
9th Apr 201410:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.